81.57
Overview
News
Price History
Option Chain
Financials
Why MET Down?
Discussions
Forecast
Dividend History
Metlife Inc stock is traded at $81.57, with a volume of 6.55M.
It is down -0.17% in the last 24 hours and up +9.11% over the past month.
MetLife is one of the largest life insurers in the US by assets and provides a variety of life insurance and annuity products. It is organized into six segments: Group Benefits, Retirement and Income Solutions, Asia, Latin America, Europe/Middle East/Africa (EMEA), and MetLife Holdings (products in run-off). Group Benefits and RIS are US-based, contributing to around 48% of the firm's 2024 adjusted earnings. The Asia segment contributes around 25% of earnings, mainly tied to Japan. The company also holds leading market positions in Mexico and Chile, with the Latin America segment contributing around 13% of 2024 earnings. The EMEA and MetLife Holdings segments contributed around 4% and 10% of 2024 earnings, respectively.
See More
Previous Close:
$81.71
Open:
$81.63
24h Volume:
6.55M
Relative Volume:
1.82
Market Cap:
$53.75B
Revenue:
$71.94B
Net Income/Loss:
$3.86B
P/E Ratio:
15.36
EPS:
5.3114
Net Cash Flow:
$15.15B
1W Performance:
-0.72%
1M Performance:
+9.11%
6M Performance:
+3.84%
1Y Performance:
+1.82%
Metlife Inc Stock (MET) Company Profile
Name
Metlife Inc
Sector
Industry
Phone
212-578-5500
Address
200 PARK AVENUE, NEW YORK, NY
Compare MET with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
MET
Metlife Inc
|
81.57 | 53.84B | 71.94B | 3.86B | 15.15B | 5.3114 |
|
MFC
Manulife Financial Corp
|
36.16 | 60.81B | 42.06B | 4.30B | 21.81B | 2.2533 |
|
AFL
Aflac Inc
|
110.36 | 57.89B | 17.70B | 4.17B | 2.57B | 7.6702 |
|
PRU
Prudential Financial Inc
|
114.99 | 40.43B | 57.61B | 2.86B | 5.27B | 7.2959 |
|
PUK
Prudential Plc Adr
|
30.84 | 38.63B | 21.69B | 3.60B | 1.36B | 2.5833 |
Metlife Inc Stock (MET) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-16-25 | Initiated | Mizuho | Outperform |
| Sep-19-25 | Downgrade | Piper Sandler | Overweight → Neutral |
| Sep-16-25 | Initiated | Wolfe Research | Outperform |
| Jan-23-25 | Initiated | BMO Capital Markets | Market Perform |
| Oct-09-24 | Initiated | TD Cowen | Buy |
| Sep-05-24 | Initiated | Barclays | Overweight |
| Jan-08-24 | Upgrade | Goldman | Neutral → Buy |
| Nov-17-23 | Resumed | Barclays | Overweight |
| Oct-05-23 | Initiated | Deutsche Bank | Hold |
| Sep-14-23 | Upgrade | Jefferies | Hold → Buy |
| Jan-09-23 | Downgrade | Goldman | Buy → Neutral |
| Dec-09-22 | Downgrade | Jefferies | Buy → Hold |
| Sep-22-22 | Initiated | Raymond James | Mkt Perform |
| Jun-23-22 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| May-24-22 | Initiated | Citigroup | Buy |
| Jan-26-22 | Initiated | Jefferies | Buy |
| Jan-21-22 | Initiated | Wolfe Research | Peer Perform |
| Jan-12-22 | Reiterated | UBS | Buy |
| Jan-05-22 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-03-21 | Initiated | Goldman | Buy |
| Apr-21-21 | Initiated | UBS | Buy |
| Jan-06-21 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-08-20 | Upgrade | Citigroup | Neutral → Buy |
| Dec-04-20 | Initiated | Goldman | Neutral |
| Nov-17-20 | Initiated | Barclays | Overweight |
| Jun-01-20 | Resumed | BofA/Merrill | Buy |
| Mar-16-20 | Upgrade | Citigroup | Sell → Neutral |
| Jan-07-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Jul-16-19 | Downgrade | Evercore ISI | Outperform → In-line |
| Mar-19-19 | Downgrade | Sandler O'Neill | Buy → Hold |
| Jan-16-19 | Upgrade | BofA/Merrill | Neutral → Buy |
| Jan-02-19 | Upgrade | Sandler O'Neill | Hold → Buy |
| Jun-04-18 | Downgrade | Goldman | Buy → Neutral |
| Apr-25-18 | Initiated | Credit Suisse | Outperform |
| Mar-26-18 | Upgrade | Atlantic Equities | Neutral → Overweight |
| Jan-02-18 | Initiated | Deutsche Bank | Hold |
| Nov-10-17 | Downgrade | Sandler O'Neill | Buy → Hold |
| Nov-03-17 | Reiterated | RBC Capital Mkts | Outperform |
| May-25-17 | Upgrade | FBR & Co. | Mkt Perform → Outperform |
| Mar-06-17 | Downgrade | BofA/Merrill | Buy → Neutral |
| Jan-26-17 | Initiated | Citigroup | Sell |
| Dec-09-16 | Downgrade | Standpoint Research | Buy → Hold |
View All
Metlife Inc Stock (MET) Latest News
Will MetLife Inc. stock gain from lower inflationMarket Activity Report & Verified Trade Idea Suggestions - Улправда
Will MetLife Inc. Depositary Shares stock beat international competitionDay Trade & Daily Stock Trend Reports - Улправда
How MetLife Inc. stock benefits from global expansionJuly 2025 PostEarnings & High Conviction Buy Zone Alerts - Улправда
Is MetLife Inc. stock dividend yield sustainableProduct Launch & Verified Swing Trading Watchlists - DonanımHaber
Is MetLife Inc. stock supported by strong fundamentalsWeekly Investment Report & Reliable Trade Execution Plans - DonanımHaber
Why MetLife Inc. stock attracts wealthy investorsMarket Growth Summary & Safe Entry Momentum Tips - DonanımHaber
Is MetLife Inc. Depositary Shares stock supported by free cash flowTrade Signal Summary & Reliable Breakout Forecasts - DonanımHaber
MetLife Partners with Global Citizen and MetLife Foundation commits $9 million as a founding donor of the FIFA Global Citizen Education Fund - Global Citizen
Is MetLife Inc. stock a safe haven assetPortfolio Growth Summary & Expert-Curated Trade Recommendations - DonanımHaber
PNB MetLife and Policybazaar Launch DigiProtect Term Insurance for Indias Salaried Individuals - Tribune India
Can MetLife Inc. (MWZ) stock sustain breakout momentumWeekly Trading Summary & Risk Adjusted Buy/Sell Alerts - DonanımHaber
Will MetLife Inc.(A19YH3) stock hit Wall Street targets2025 Price Targets & Entry and Exit Point Strategies - DonanımHaber
Can MetLife Inc. stock deliver sustainable ROETrade Volume Summary & AI Forecast for Swing Trade Picks - DonanımHaber
Pharma News: Why MetLife Inc. stock could rally in 2025July 2025 Sector Moves & Expert-Curated Trade Recommendations - Улправда
Will MetLife Inc.(MWZG) stock rise with strong economyEarnings Trend Report & Daily Profit Focused Screening - DonanımHaber
MetLife (MET) Valuation Review as New Petstablished Partnership Expands Its Pet Insurance Reach - Yahoo Finance
MetLife expands pet insurance reach through Petstablished partnership - MSN
Stop Loss: Why MetLife Inc. stock could rally in 2025July 2025 Big Picture & Entry Point Strategy Guides - Улправда
MetLife Expands Pet Insurance Reach Through Petstablished Partnership - Yahoo Finance
Is MetLife Inc. Depositary Shares stock supported by strong fundamentalsWeekly Stock Analysis & Risk Managed Investment Signals - Улправда
Can MetLife Inc. (MWZ) stock stage a strong rebound this quarterTrade Performance Summary & Growth Focused Entry Reports - Улправда
Why MetLife Inc. stock remains a top recommendation2025 Analyst Calls & Daily Technical Stock Forecast Reports - Улправда
Texas Permanent School Fund Corp Has $4.81 Million Stock Holdings in MetLife, Inc. $MET - MarketBeat
MetLife Pet Insurance partners with Petstablished to integrate coverage at adoption - Insurance Business
MetLife Pet Insurance to Offer Quotes on Petstablished Platform - marketscreener.com
MetLife (MET) Partners with Petstablished to Streamline Pet Insu - GuruFocus
MetLife Pet Insurance partners with Petstablished to offer coverage at adoption - Investing.com India
MetLife Pet Insurance Collaborates with Petstablished to Make Pet Coverage Easy at Adoption - Yahoo Finance
MetLife (NYSE:MET) Rating Increased to Strong-Buy at Mizuho - MarketBeat
Mizuho Initiates Coverage of MetLife (MET) with Outperform Recommendation - Nasdaq
Berkshire Hathaway vs. MetLife: Which Insurance Giant Stands Out? - Finviz
Mizuho Initiates Coverage on MetLife (MET) with Outperform Ratin - GuruFocus
Mizuho Initiates MetLife at Outperform With $101 Price Target - marketscreener.com
Corient Private Wealth LLC Buys 462,367 Shares of MetLife, Inc. $MET - MarketBeat
Mizuho initiates MetLife stock coverage with Outperform rating, $101 target By Investing.com - Investing.com Nigeria
Mizuho initiates MetLife stock coverage with Outperform rating, $101 target - Investing.com
Morgan Stanley Adjusts Price Target on MetLife to $101 From $97, Maintains Overweight Rating - marketscreener.com
FORA Capital LLC Invests $2.35 Million in MetLife, Inc. $MET - MarketBeat
How Do Investors Really Feel About MetLife Inc? - Benzinga
Occudo Quantitative Strategies LP Acquires Shares of 102,933 MetLife, Inc. $MET - MarketBeat
US59156RAM07 Bond Price and Chart — SWB:US59156RAM07 - TradingView — Track All Markets
MetLife Inc. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
MetLife’s Massive Annuity Risk Transfer Could Be A Game Changer For MetLife (MET) - Yahoo Finance
State Street Corp Has $2.09 Billion Stock Holdings in MetLife, Inc. $MET - MarketBeat
MetLife's Asset Management Arm Expands Reach With PineBridge Buyout - MSN
MetLife Inc. stock outperforms competitors on strong trading day - MarketWatch
iSAM Funds UK Ltd Buys New Shares in MetLife, Inc. $MET - MarketBeat
Lombard Odier Asset Management Switzerland SA Has $2.58 Million Stake in MetLife, Inc. $MET - MarketBeat
MetLife gets positive feedback from analysts - MSN
MetLife Gets Positive Feedback from Analysts - Insider Monkey
MetLife, Inc. $MET Shares Purchased by Natixis - MarketBeat
Metlife Inc Stock (MET) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):